Vol 2, No 4 (December 2013): Chinese Clinical Oncology (Hepatocellular carcinoma - Guest Editor: Ghassan K. Abou-Alfa)

Review Articles

Viral hepatitis, non-alcoholic fatty liver disease and alcohol as risk factors for hepatocellular carcinoma
Maya Gambarin-Gelwan
A review of hepatocellular carcinoma (HCC) staging systems
Somasundaram Subramaniam, Robin K. Kelley, Alan P. Venook
Management of liver cirrhosis in patients with hepatocellular carcinoma
Bahaa Eldeen Senousy Ismail, Roniel Cabrera
Hepatocellular carcinoma in the modern era: transplantation, ablation, open surgery or minimally invasive surgery?—A multidisciplinary personalized decision
Ioannis T. Konstantinidis, Yuman Fong
Percutaneous therapies of hepatocellular carcinoma—an update
Julius Chapiro, Jean-François Henri Geschwind
Systemic therapy for hepatocellular carcinoma
James J. Harding, Ghassan K. Abou-Alfa
Features and treatment options of Chinese hepatocellular carcinoma
Qiong Wu, Shu-Kui Qin
Status of hepatocellular carcinoma in South Korea
Seung Kew Yoon, Hoo Geun Chun
Current status of hepatocellular carcinoma in Japan
Masafumi Ikeda, Shuichi Mitsunaga, Satoshi Shimizu, Izumi Ohno, Hideaki Takahashi, Hiroyuki Okuyama, Akiko Kuwahara, Takuji Okusaka
Hepatocellular carcinoma in India
Gouri Shankar Bhattacharyya, K. Govind Babu, Hemant Malhotra, Anantbhushan A Ranade, Shaiqua Murshed, Debasis Datta
Status of hepatocellular carcinoma in Gulf region
Kakil Ibrahim Rasul, Safaa H. Al-Azawi, Prem Chandra, Ghassan K. Abou-Alfa, Alexander Knuth
Risk factors for developing hepatocellular carcinoma in Egypt
Ashraf Omar, Ghassan K. Abou-Alfa, Ahmed Khairy, Heba Omar
Status of hepatocellular cancer in Europe
Alexa Childs, James O’Beirne, Tim Meyer
Current status of hepatocellular carcinoma in the United States
Andrew X. Zhu